{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:27:08Z","timestamp":1791584828797,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["295989"],"award-info":[{"award-number":["295989"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/W011581\/2"],"award-info":[{"award-number":["MR\/W011581\/2"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbih.2026.101185","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:16:56Z","timestamp":1769793416000},"page":"101185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer's disease risk: a Mendelian randomization study"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0949-6554","authenticated-orcid":false,"given":"Christina N.","family":"Kushnir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Taylor-Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbih.2026.101185_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1547185","article-title":"Cerebrospinal fluid levels of tumour necrosis factor-\u03b1 and its receptors are not associated with disease progression in Alzheimer's disease","volume":"17","author":"Aljuhani","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.bbih.2026.101185_bib2","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00125-023-05875-x","article-title":"Drug target Mendelian randomization: are we really instrumenting drug use?","volume":"66","author":"Anderson","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbih.2026.101185_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2019.09.003","article-title":"Mendelian randomization indicates that TNF is not causally associated with Alzheimer's disease","volume":"84","author":"Andrews","year":"2019","journal-title":"Neurobiol. Aging"},{"issue":"33","key":"10.1016\/j.bbih.2026.101185_bib4","article-title":"Systemic inflammation as a central player in the initiation and development of Alzheimer's disease","volume":"22","author":"Bayraktaroglu","year":"2025","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.bbih.2026.101185_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbih.2026.101185_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/msb.2009.17","article-title":"Tisue specificity and the human protein interaction network","volume":"5","author":"Bossi","year":"2009","journal-title":"Mol. Syst. Biol."},{"issue":"21","key":"10.1016\/j.bbih.2026.101185_bib7","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1212\/WNL.0000000000001617","article-title":"Etanercept in Alzheimer disease: a randomized, placebo-controlled, double-blind, phase 2 trial","volume":"84","author":"Butchart","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.bbih.2026.101185_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/1179573517709278","article-title":"Tumor necrosis factor \u03b1 inhibition for Alzheimer's disease","volume":"9","author":"Chang","year":"2017","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.bbih.2026.101185_bib9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s40263-016-0374-z","article-title":"Treatment for rheumatoid arthritis and risk of alzheimer's disease: a nested case-control analysis","volume":"30","author":"Chou","year":"2016","journal-title":"CNS Drugs"},{"issue":"37","key":"10.1016\/j.bbih.2026.101185_bib10","article-title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alz Res. Therapy"},{"key":"10.1016\/j.bbih.2026.101185_bib11","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.bbih.2026.101185_bib12","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.bbih.2026.101185_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbih.2026.101185_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.12688\/wellcomeopenres.16544.1","article-title":"Mendelian randomization for studying the effects of perturbing drug targets","volume":"6","author":"Gill","year":"2021","journal-title":"Wellcome Open Res."},{"issue":"3","key":"10.1016\/j.bbih.2026.101185_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/ije\/dyy202","article-title":"Contextualizing selection bias in Mendelian randomization: how bad is it likely to be?","volume":"48","author":"Gkatzionis","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbih.2026.101185_bib16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbih.2026.101185_bib17","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/ije\/dyx028","article-title":"Two-sided Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique","volume":"45","author":"Hartwig","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbih.2026.101185_bib18","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Baird D, Haberland V et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 7:e34408. https:\/\/doi.org\/10.7554\/eLife.34408.","DOI":"10.7554\/eLife.34408"},{"issue":"3","key":"10.1016\/j.bbih.2026.101185_bib19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s13311-019-00715-6","article-title":"Can disease-modifying anti-rheumatic drugs reduce the risk of developing dementia in patients with rheumatoid arthritis?","volume":"16","author":"Huang","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbih.2026.101185_bib20","first-page":"159","article-title":"TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus","volume":"9","author":"Jayaraman","year":"2021","journal-title":"BMC ANC"},{"issue":"27","key":"10.1016\/j.bbih.2026.101185_bib21","article-title":"The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease","volume":"6","author":"Jochemsen","year":"2014","journal-title":"Alz Res. Therapy"},{"key":"10.1016\/j.bbih.2026.101185_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-47971-5","article-title":"Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases","volume":"15","author":"Karlsson","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbih.2026.101185_bib23","first-page":"575","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement TRCI"},{"issue":"3","key":"10.1016\/j.bbih.2026.101185_bib24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.bbih.2026.101185_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002690","article-title":"Enhancing the prioritization of disease-causing genes through tissue specific protein interaction networks","volume":"8","author":"Magger","year":"2012","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.bbih.2026.101185_bib26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ije\/dyx206","article-title":"Collider scope: when selection bias can substantially influence observed associations","volume":"47","author":"Munaf\u00f2","year":"2018","journal-title":"Int. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.bbih.2026.101185_bib27","article-title":"Genetically proxied IL\u20106 signaling and risk of Alzheimer's disease and lobar intracerebral hemorrhage: a drug target Mendelian randomization study","volume":"10","author":"Myserlis","year":"2024","journal-title":"Alzheimers Dement TRCI"},{"issue":"13","key":"10.1016\/j.bbih.2026.101185_bib28","article-title":"Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060","volume":"10","author":"Nandi","year":"2024","journal-title":"npj Aging"},{"key":"10.1016\/j.bbih.2026.101185_bib29","series-title":"Leading Causes of Death. [Online]","year":"2024"},{"issue":"38","key":"10.1016\/j.bbih.2026.101185_bib30","article-title":"Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis: a multi-national multi-database case-control study","volume":"12","author":"Newby","year":"2020","journal-title":"Alzheimers Res. Ther."},{"issue":"2","key":"10.1016\/j.bbih.2026.101185_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"issue":"4","key":"10.1016\/j.bbih.2026.101185_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbih.2026.101185_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","article-title":"Dynamics of brain-derived proteins in cerebrospinal fluid","volume":"310","author":"Reiber","year":"2001","journal-title":"Clin. Chim. Acta"},{"issue":"5281","key":"10.1016\/j.bbih.2026.101185_bib34","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1126\/science.273.5281.1516","article-title":"The future of genetic studies of complex human diseases","volume":"273","author":"Risch","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbih.2026.101185_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152083","article-title":"Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs \u2013 analysis of a national claims database","volume":"57","author":"Sattui","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.bbih.2026.101185_bib36","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41562-023-01579-9","article-title":"Participation bias in the UK Biobank distorts genetic associations and downstream analyses","volume":"7","author":"Schoeler","year":"2023","journal-title":"Nat. Hum. Behav."},{"issue":"1","key":"10.1016\/j.bbih.2026.101185_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ije\/dyh132","article-title":"Mendelian randomization: prospects, potentials, and limitations","volume":"33","author":"Smith","year":"2004","journal-title":"Int. J. Epidemiol."},{"issue":"7982","key":"10.1016\/j.bbih.2026.101185_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbih.2026.101185_bib39","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbih.2026.101185_bib40","first-page":"25","article-title":"TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study","volume":"8","author":"Tobinick","year":"2006","journal-title":"Medsc. Gen. Med."},{"key":"10.1016\/j.bbih.2026.101185_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106325","article-title":"TNF inhibitors have a protective role in the risk of dementia in patients with ankylosing spondylitis: results from a nationwide study","volume":"182","author":"Watad","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbih.2026.101185_bib42","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41588-024-01972-8","article-title":"Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's disease","volume":"56","author":"Western","year":"2024","journal-title":"Nat. Genet."},{"issue":"R13","key":"10.1016\/j.bbih.2026.101185_bib43","article-title":"Variation in tissue-specific gene expression among natural populations","volume":"6","author":"Whitehead","year":"2005","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.bbih.2026.101185_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-004016","article-title":"Association between disease-modifying antirheumatic drugs for rheumatoid arthritis and risk of incident dementia: a systematic review with meta-analysis","volume":"10","author":"Xie","year":"2024","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.bbih.2026.101185_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229819","article-title":"Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis","volume":"15","author":"Zhou","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbih.2026.101185_bib46","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","article-title":"Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches","volume":"109","author":"Zuber","year":"2022","journal-title":"Am. J. Hum. Genet."}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626000189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626000189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:13:17Z","timestamp":1777637597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354626000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"alternative-id":["S2666354626000189"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101185","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer's disease risk: a Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101185"}}